Skip to main content
SpringerLink
Log in

Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Local environmental signals regulate the growth and development of both normal and malignant breast epithelium. Members of the insulin-like growth factor (IGF) family likely influence both of these processes. The localization of IGF2 to stroma specifically surrounding malignant breast epithelium indicates that this growth factor may play a critical role in the genesis or maintenance of this transformed phenotype. Recent studies have sought to understand the mechanism by which IGF2 expressing fibroblasts are localized to the periphery of malignant breast cancer cells. In addition, the consequences of the expression of IGF-signaling components likely expand beyond their direct effects on mitogenesis. Indirect effects predominantly associated with the IGF2 receptor could also influence the invasive potential of breast tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sakakura T, Nishizuka Y, Dawe CJ: Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J Natl Cancer Inst 63:733–736, 1979

    Google Scholar 

  2. Sakakura T, Sakagami Y, Nishizuka Y: Persistence of responsiveness of adult mammary gland to induction by embryonic mesenchyme. Dev Biol 72: 201–210, 1979

    Google Scholar 

  3. Streuli CH, Bailey N, Bissel MJ: Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol 115:1383–1395, 1991

    Google Scholar 

  4. Streuli CH, Bissel MJ: Expression of extracellular matrix components is regulated by substratum. J Cell Biol 110:1405–1415, 1990

    Google Scholar 

  5. Petersen OW, Rønnov-Jessen L, Howlett AR, Bissel MJ: Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064–9068, 1992

    Google Scholar 

  6. Adams EF, Newton CJ, Braunsberg H, Shaikh N, Ghilchik M, James VHT: Effects of human breast fibroblasts on growth and 17β-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res Treat 11:165–172, 1988

    Google Scholar 

  7. Ryan MC, Orr DJA, Horgan K: Fibroblast stimulation of breast cancer cell growth in a serum-free system. Br J Cancer 67:1268–1273, 1993

    Google Scholar 

  8. Schor AM, Rushton G, Ferguson JE, Howell A, Redford J, Schor SL: Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int J Cancer 59:25–32, 1994

    Google Scholar 

  9. Brouty-Boye D, Mainguene C, Magnien V, Israel L, Beaupain R: Fibroblast-mediated differentiation in human breast carcinoma cells (MCF-7) grown as nodules in vitro. Int J Cancer 56:731–735, 1994

    Google Scholar 

  10. Azzarone B, Marcel M, Billard C, Scemama P, Chaponnier C, Macieira-Coelho A: Abnormal properties of skin fibroblasts from patients with breast cancer. Int J Cancer 33:759–764, 1984

    Google Scholar 

  11. Durning P, Schor SL, Sellwood RAS: Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet ii:890–892, 1984

    Google Scholar 

  12. Schor SL, Haggie J, Durning P, Howell A, Sellwood RAS, Crowther D: The occurrence of a foctal fibroblast phenotype in breast cancer. Int J Cancer 37:831–836, 1986

    Google Scholar 

  13. Haggie J, Schor SL, Howell A. Birch JM, Sellwood RAS: Fibroblasts from relatives of hereditary breast cancer display foetal-like behaviour in vitro. Lancet i:1455–1457, 1987

    Google Scholar 

  14. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16:3–34, 1995

    Google Scholar 

  15. Nishimoto I, Murayama Y, Katada T, Um M, Ogata E: Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins. J Biol Chem 264:14029–14038, 1989

    Google Scholar 

  16. Korner C, Nurnberg B, Uhde M, Braulke T: Mamose 6-phosphate/insulin-like growth factor-II receptor fails to interact with G-proteins. J Biol Chem 270:287–295, 1995

    Google Scholar 

  17. Filson AJ, Louvi A, Efstratiadis A, Robertson EJ: Rescue of the T-associated maternal effect in mice carrying null mutations in Igf-2 and M6P/IGF2R, two reciprocally imprinted genes. Development 118:731–736, 1993

    Google Scholar 

  18. Ellis MJC, Leav BA, Yang Z, Rasmussen A, Pearce A, Zwibel JA, Lippman ME, Cullen KJ: Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286–297, 1996

    Google Scholar 

  19. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD, Jirtle RL: M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12:2003–2009, 1996

    Google Scholar 

  20. Bondy CA, Werner AH, Roberts CT Jr, LeRoith D: Cellular pattern of insulin-like growth factor-1 (IGF1) and type-1 IGF receptor gene expression in early organogenesis: comparison with IGF2 gene expression. Mol Endocrinol 4:1386–1398, 1990

    Google Scholar 

  21. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (IGF1) and Type I IGF receptor (IGF1r). Cell 75:59–72, 1993

    Google Scholar 

  22. DeChiara TM, Efstratiadis A, Robertson EJ: A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80, 1990

    Google Scholar 

  23. Voss JW, Rosenfeld MG: Anterior pituitary development: short tales from dwarf mice. Cell 70:527–530, 1992

    Google Scholar 

  24. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363–1367, 1996

    Google Scholar 

  25. Baserga R, Rubin R: Cell cycle and growth control. Critical Rev Eukatyotic Gene Expr 3:47–61, 1993

    Google Scholar 

  26. Resnicoff M, Burgaud J-L, Rotman HL, Abraham D, Baserga R: Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739–3741, 1995

    Google Scholar 

  27. Cullen KJ, Yee D, Rosen N: Insulin-like growth factors in human malignancy. Cancer Invest 9:443–454, 1991

    Google Scholar 

  28. Singer C. J Clin Endo Metab, in press, 1997

  29. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD: Growth enhancement of transgenic mice expressing human insulin-like growth factor 1. Endocrinology 123:2827–2833, 1988

    Google Scholar 

  30. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R: Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269:13779–13784, 1994

    Google Scholar 

  31. Bates P, Fisher R, Ward A, Richardson L, Hill J, Graham CF: Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189–1193, 1995

    Google Scholar 

  32. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48–53, 1990

    Google Scholar 

  33. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509–517, 1989

    Google Scholar 

  34. Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696, 1988

    Google Scholar 

  35. Toropainen E, Lipponen P, Syrjänen K: Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis. Eur J Cancer 31A: 1443–1448, 1995

    Google Scholar 

  36. Toropainen EM, Lipponen PK, Syrjänen KJ: Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long-term prognosis. Anticancer Res 15: 2669–2674, 1995

    Google Scholar 

  37. Pekonen F, Partanen S, Makinen T, Rutanen EM: Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343–1347, 1988

    Google Scholar 

  38. Paik S: Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Res Treat 22:31–38, 1992

    Google Scholar 

  39. Giani C, Cullen KJ, Campani D, Rasmussen A: IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study. Breast Cancer Res Treat 41:43–50, 1996

    Google Scholar 

  40. Cullen KJ, Smith HS, Hill S, Paik S, Rosen N, Lippman ME: Growth factor mRNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 51:4978–4985, 1991

    Google Scholar 

  41. Singer C, Rasmussen A, Smith HS, Lippman ME, Cullen KJ: Malignant breast epithelium induces insulin-like growth factor II expression in breast stroma. Evidence for paracrine function. Cancer Res 55:2448–2454, 1995

    Google Scholar 

  42. Manni A, Badger B, Wei L, Zaenglein A, Grove R, Khin S, Heitjan D, Shimasaki S, Ling N: Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res 54:2934–2942, 1994

    Google Scholar 

  43. Ruan W, Newman CB, Kleinberg DL: Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 89:10872–10876, 1992

    Google Scholar 

  44. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR: Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 55:467–471, 1995

    Google Scholar 

  45. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery J-P, Koteliansky VE: Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90:999–1003, 1993

    Google Scholar 

  46. Rønnov-Jessen L, Petersen OW, Koteliansky VE, Bissel MJ: The origin of myofibroblasts in breast cancer. J Clin Invest 95:859–873, 1995

    Google Scholar 

  47. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1–4, 1994

    Google Scholar 

  48. Singleton JR, Dixit VM, Feldman EL: Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 271: 31791–31794, 1996

    Google Scholar 

  49. O'Conner R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA: Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 17:427–435, 1997

    Google Scholar 

  50. Pollak MN, Huynh HT, Lefebvre SP: Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res Treat 22:91–100, 1992

    Google Scholar 

  51. Ellis MJ, Singer C, Hornby A, Rasmussen A, Cullen KJ: Insulin-like growth factor stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 31:153–165, 1994

    Google Scholar 

  52. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N, Zwibel JA: Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6:91–100, 1992

    Google Scholar 

  53. Lee AV, Darbre P, King RJB: Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol 99:211–220, 1994

    Google Scholar 

  54. Bonneterre J, Peyrat JP, Beuscart R, Demaille A: Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res 50:6931–6935, 1990

    Google Scholar 

  55. Stewart AJ, Johnson MD, May FEB, Westley BR: Role of IGFs and the type I IGF receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172–21178, 1990

    Google Scholar 

  56. Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F: Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 4:1327–1335, 1990

    Google Scholar 

  57. Osborne CK, Clemmons DR, Arteaga CL: Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Molec Biol 37:805–809, 1992

    Google Scholar 

  58. Pekonen F, Nyman T, Ilvesmäki V, Partanen S: Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res 52:5204–5207, 1992

    Google Scholar 

  59. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D: Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601–606, 1996

    Google Scholar 

  60. van der Berg HW, Claffie D, Boylan M, McKillen J, Lynch M, McKibben B: Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related to the effect of steroid hormone on insulin-like growth factor I expression. Br J Cancer 73:477–481, 1996

    Google Scholar 

  61. Helle SI, Anker, GB, Tally M, Hall K, Lonning PE: Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients. J Steroid Biochem Mol Biol 57:167–171, 1996

    Google Scholar 

  62. Brünner N, Yee D, Kern FG, Spang-Thomsen M, Lippman ME, Cullen KJ: Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II). Eur J Cancer 29A:562–569, 1993

    Google Scholar 

  63. Arteaga CL, Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49:6237–6241, 1989

    Google Scholar 

  64. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989

    Google Scholar 

  65. Kenney NJ, Dickson RB: Growth and sex steroid interactions in breast cancer. J Mammary Gland Biol Neoplasia 1:189–198, 1996

    Google Scholar 

  66. Daws MR, Westley BR, May FEB: Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol. Endocrinology 137:1177–1186, 1996

    Google Scholar 

  67. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL: Cathepsin D and prognosis in breast cancer. N Engl J Med 322:297–302, 1990

    Google Scholar 

  68. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rouessé J, Rochefort H: Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet ii:1115–1118, 1989

    Google Scholar 

  69. Hoeflich A, Wolf E, Braulke T, Koepf G, Kessler U, Brem G, Rascher W, Blum WF, Liess W: Does the overexpression of pro-insulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes? Eur J Biochem 232:172–178, 1995

    Google Scholar 

  70. De Leon DD, Terry C, Asmerom Y, Nissley P: Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells. Endocrinology 137:1851–1859, 1996

    Google Scholar 

  71. Briozzo P, Morisset M, Capony F, Rougeot C, Rochefort H: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Res 48:3688–3692, 1988

    Google Scholar 

  72. Henry JA, McCarthy AL, Angus B, Westley BR, May FEB, Nicholson S, Cairns J, Harris AL, Horne CHW: Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer 65:265–271, 1990

    Google Scholar 

  73. Johnson MD, Torri JA, Lippman ME, Dickson RB: The role of cathepsin D in the invasiveness of human breast cancer. Cancer Res 53:873–877, 1993

    Google Scholar 

  74. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161–195, 1993

    Google Scholar 

  75. Dennis PA, Rifken DB: Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin like growth factor type II receptor. Proc Natl Acad Sci USA 88:580–584, 1991

    Google Scholar 

  76. Dalal BI, Keown PA, Greenberg AH: Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 143:381–389, 1993

    Google Scholar 

  77. Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 14:297–307, 1996

    Google Scholar 

  78. Arnoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL, Tuszynski GP: Thrombo spondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76:998–1005, 1995

    Google Scholar 

  79. Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M: Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155:595–605, 1993

    Google Scholar 

  80. Minniti CP, Kohn EC, Grubb JH, Sly WS, Oh Y, Mueller HL, Rosenfeld RG, Helman LJ: The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J Biol Chem 267:9000–9004, 1992

    Google Scholar 

  81. Nakao-Hayashi J, Ito H, Kanayasu T, Morita I, Muiota S-I: Stimulatory effects of insulin and insulin-like growth factor 1 on migration and tube formation by vascular endothelial cells. Atherosclerosis 92:141–149, 1992

    Google Scholar 

  82. Klemke RL, Yebra M, Bayna EM, Cheresh DA: Receptor tyrosine kinase signaling required for integrin alpha V beta 5-directed cell motility but not adhesion on vitronectin. J Cell Biol 127:859–866, 1994

    Google Scholar 

  83. Jones JI, Prevette T, Gockerman A, Clemmons DR: Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor I. Proc Natl Acad Sci USA 93:2482–2487, 1996

    Google Scholar 

  84. Doerr ME, Jones JI: The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem 271:2443–2447, 1996

    Google Scholar 

  85. Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffmann E: The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 264:21544–21549, 1989

    Google Scholar 

  86. Grant MB, Guay C, Marsh R: Insulin-like growth factor I stimulates proliferation, migration, and plasminogen activator release by human retinal pigment epithelial cells. Curr Eye Res 9:323–335, 1990

    Google Scholar 

  87. Volpert O, Jackson D, Bouck N, Linzer DIH: The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137:3871–3876, 1996

    Google Scholar 

  88. Beukers MW, Oh Y, Zhang H, Ling N, Rosenfeld R: [Leu 27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, crosslinking and thymidine incorporation experiments. Endocrinology 128:1201–1203, 1991

    Google Scholar 

  89. Roesel JF, Nanney LB: Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res 58:449–459, 1995

    Google Scholar 

  90. Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J: Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 36:282–291, 1993

    Google Scholar 

  91. Lefaucheur J-P, Gjata B, Lafont H, Sebille A: Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-β1. J Neuroimmunology 70:37–41, 1996

    Google Scholar 

  92. Pepper MS, Vassalli J-D, Orci L, Montesano R: Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 204:356–363, 1993

    Google Scholar 

  93. Briozzo P, Badet J, Capony F, Pieri I, Montcourrier P, Barritault D, Rochefort H: MCF-7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 194: 252–259, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC, USA

    Audrey A. Rasmussen & Kevin J. Cullen

Authors
  1. Audrey A. Rasmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin J. Cullen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rasmussen, A.A., Cullen, K.J. Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat 47, 219–233 (1998). https://doi.org/10.1023/A:1005903000777

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005903000777

Search

Navigation